ABSTRACT. Myoblast cells, C2C12, which is an established cell line from satellite cells of skeletal muscle of C3Hmouse, start to fuse and form multinucleated cells (myotubes) and begin to express creatine phosphokinase and myosin, whenculture mediumis changed from the growth mediumto the differentiation medium.Among the 12 lectins that we tested, wheat germ agglutinin apparently suppressed the myotube development judged by phase-contrast microscopy, but did not affect the induction of creatine phosphokinase activity. The addition of N-acetylglucosamine or N,N',N"-triacetylchitotriose, which is a specific ligand for wheat germ agglutinin, to the differentiation medium,recovered this apparently suppressive effect of wheat germ agglutinin on the myotube development. Tachypleus tridentatus (Japanese horseshoe crab) lectin that specifically recognizes N-acetylneuraminic acid, one of the sialic acids, showedno effect on the myotubedevelopment. It was suggested that wheat germ agglutinin suppressed the process through recognizing N-acetylglucosamine containing sugar. Surprisingly, even in the presence of wheat germ agglutinin, the ratio of mononucleated cell numbers to the genomic DNA content, which represents the fusion level, decreased after incubation in the differentiation medium, indicating that even when wheat germ agglutinin was present in the medium, cell fusion, which is the initial step of the myotube formation, occurred. Immunostaining with anti-skeletal muscle myosin antiserum confirmed that the myosin expressing cells actually fused and formed multinucleated cells. Their shape, however, was thin compared to that in the absence of wheat germ agglutinin. Wepropose that the membranefusion step to form myotubes is composed of two distinct steps in C2C12; one fusion step is to form long and thin myotubes from mononucleated cells and the other one is to develop fat myotubes. Wheat germ agglutinin specifically inhibits the latter fusion step.
During the terminal differentiation of myogenesis, myoblasts fuse to form multinucleated myotubes. To date, several proteins that are involved in the process of myoblast fusion have been reported. Neural cell adhesion molecule (N-CAM)and N-cadherin are expected to function in the initial recognition step for the fusion of embryonic chicken myoblasts (1-4). However, the specific antibodies against the proteins do not inhibit the myoblast fusion efficiently (1, (3) (4) (5) . Both VLA-4 (integrin a4/31) and vascular cell adhesion molecule 1 (VCAM-1)play important roles in the cell to cell recognition at the stage of secondary myoblast fusion to form mature myotubes in vivo (5). The monoclonal antibody raised against either VLA-4 or VCAM-1effective-ly inhibits the myotube formation of C2C12 cells (5). Besides these four proteins, many other proteins are reported to be involved in the fusion of myoblasts (6-1 1). Myoblast fusion is expected to be controlled by proteins localized on the cell surface. Manyof them are glycoproteins. Tunicamycin, an inhibitor for protein glycosylation, inhibits myotube formation (12, 13) . Actually, almost all the proteins that are expected to play roles in the myoblast fusion described above are glycoproteins.
Therefore, the lectins that recognize specific structure of the sugar chain are useful tools to examine the myoblast fusion. At present, concanavalin A (ConA) and wheat germ agglutinin (WGA)are known to inhibit the fusion of primary culture of chicken myoblasts (14) . The inhibitory effect of ConAwas not specific on the myoblast fusion but on the entire myogenicprocess of the cells (15, 16) .
We tested the effect of 12 lectins on the myotube for-* Towhom correspondenceshould be addressed. Abbreviations: N-CAM,neural cell adhesion molecule; VCAM-1, vascular cell adhesion molecule 1; ConA, concanavalin A; WGA, wheat germ agglutinin; DBA, Dolichos biflorus lectin; LCA,, Lens culinaris agglutinin; MAM, Maackia amurensis lectin; PNA, peanut lectin; RCA-120, Ricinus communis lectin 120 (RCA-120); SBA, soybean lectin; SSA, Sambucus sieboldiana lectin; UEA-I, Ulex europaeus lectin-I; AAL, Aleuria aurantia lectin; TTA, Japanese horseshoe crab lectin; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; TAC, N,N',N"-triacetylchitotriose;
MCK,muscle creatine phosphokinase; PBS (-), calcium-magnesium free Dulbecco's phosphate buffered saline. mation in C2C12cells, and found that one of the tested lectins, WGA,specifically suppressed the development of the myotubes without affecting the initial myoblast fusion.
MATERIALS AND METHODS

Materials.
Dulbecco's modified Eagle's medium (DMEM) was purchased from Nissui Seiyaku (Tokyo, Japan), and Cosmedium was from CosmoBio (Tokyo, Japan). Fetal bovine serum (FBS) and G418 were obtained from Gibco BRL Japan (Tokyo). Trypsin was from DIFCO (Detroit, Michigan), and gelatin was from Iwaki Glass (Tokyo, Japan). ConA, Dolichos biflorus lectin (DBA), Lens culinaris agglutinin (LCA), Lotus tetragonolobus lectin (lotus lectin), Macckia amurensis lectin (MAM), peanut lectin (PNA), Ricinus communis lectin 120 (RCA-120), soybean lectin (SBA), Sambucus sieboldiana lectin (SSA), Ulex europaeus lectin-I (UEA-I), and WGA were purchased from Honen Corp. (Tokyo, Japan). Aleuria aurantia lectin (AAL) and Japanese horseshoe crab lectin (TTA) were from Nichirei (Tokyo, Japan) and Seikagakukogyo Corp. (Tokyo, Japan), respectively. N,N',N"-triacetylchitotriose (TAC), penicillin, and streptomycin were obtained from Sigma (St. Louis, Missouri). Hoechst 33258 and goat anti-rabbit antibody-peroxidase were obtained from WakoPure Chemicals (Osaka, Japan). The other chemicals used were of the highest quality available.
Methods.
Cells and Cell Culture. Mouse skeletal muscle myoblast cell line, C2C12, and its transformant, MTR4C (17), were maintained as monolayers in a humidified incubator (5% CO2) at 37°C in plastic dishes that were coated with 1% gelatin, containing DMEMsupplemented with \0% FBS, 100 u /ml of penicillin, and 100 /ig/ml of streptomycin. As for maintaining MTR4C, 4-5 mg/ml of G418 in 0.1 M Hepes-NaOH, pH 7.4, was added at 0.2 mg/ml to the culture medium. Two days prior to the experiment, samples of 1x105 cells of C2C12 or 2 x 105 cells ofMTR4Cwere seeded into 60-mm plastic dishes containing 3 ml of growth medium. On day 2 of cell growth, the growth mediumwas replaced by 3 ml of Cosmedium, the differentiation inducing medium (18). Every 24 h, the differentiation mediumwith or without appropriate concentration of lectin was changed for the fresh one. Each lectin was added to the differentiation mediumat various concentrations (0.2-10 /ig/ml) after 12 or 6 h incubation, and the incubation was continued for 72 or 48 h for C2C12 or MTR4C,respectively (Fig. 1) Determination of the mononucleated cell numbers and the Fig. 2 . Effects ofWGAon the myotube development. C2C12 cells (A) and MTR4C(B) were cultured in the growth medium. The medium was then changed to the differentiation medium and the culture was continued for 72 h for C2C12 (C, E), and 48 h for MTR4C(D, F), with (E, F) or without (C, D) WGA(2 /*g/ml). The bar indicates 100 /mi. total DNAcontent. The C2C12 cells in 60-mm dish were washed with PBS (-), and dissociated with 1 ml of 0.25% trypsin and 0.02% EDTAat 37°C for 15 min. The cells were suspended and the cell numbers were counted in a hemocytometer. A small portion of the cell suspension was fixed with 3.7% formaldehyde on coverglass coated with poly-L-lysine (Sigma) for 10 min. The fixed cells were stained with Mayerhaematoxylin (MERCK),and the numbers of nuclei per cell were counted. More than 99%of the counted cells contained one nucleus. From the rest of cell suspension, the genomic DNAwas isolated as described previously (22). The genomic DNAthus prepared was dissolved in 0.5 ml of 10mMTris-HC1, 1 mMEDTA(pH 8.0) and was briefly sonicated. An aliquot of this fraction was added to 200 /ig/ml of Hoechst 33258 to a final concentration of 1^g/ml (23). The reaction mixture was excited at 356 nmand an emission at 456 mmwas measured. Salmonsperm DNAwas used as a standard.
Immunostaining of Myotube Using Anti-myosin Antiserum. The cells induced to differentiate were washed with ice cold PBS (-) and fixed with methanol at -20°C for 5 min. The cells were then washed with PBS(-), and soaked with 3% H2O2 for 5 min to inactivate endogenous peroxidase. The cells were washed again with PBS (-) and incubated with rabbit anti-myosin antiserum in the antibody buffer (1% bovine serum albumin and 0.02% sodium azide in PBS (-)) at room temperature for 90min. The antiserum used was raised against mouse skeletal muscle myosin heavy chain. After the 
After 48 h incubation in the differentiation medium, the myotube formation was judged and the MCKactivity was determined as described in the "MATERIALSANDMETHODS".When no "typical" myotube was observed, the myotube formation was expressed as (-). Whenmorethan one myotubewas found in a dish, the myotubeformation was expressed as (+). The MCKactivity was expressed as percent of the specific activity of the C2C12cells cultured in the absence of lectin. The lectins were classified into three groups: I, myotube (-) and MCKnormal; II, myotube (+) and MCKnormal; III, myotube (-) and MCK induction inhibited.
incubation, the cells were washed with PBS(-). Next, the cells were incubated with anti-rabbit antibodies conjugated to peroxidase in PBS (-) at room temperature for 30 min, and then washed with PBS (-). The bound second antibodies were visualized using a color reaction buffer containing 0.4 mg/ml 3-amino-9-ethylcarbazole, 0.03% H2O2 in 50 mMsodiumacetate, pH 5.3. Nuclei DNAwas stained with Mayer-haematoxylin according to the manufacturer's protocol (Daiichi Pure Chemicals; Tokyo, Japan). . In contrast, apparently, no typical myotube was observed when WGA(2 /ig/ml), AAL (10 [ig /ml), LCA (10 /ig/ml), RCA-120 (0.2 /ig/ml), SSA (2 /ig/ml), or MAM(10 /ig/ml) was added to Cosmedium. ConA (5 jug/ml), 10 /ig/ml each of DBA, SBA, PNA, lotus lectin, or UEA-I showed no effect on the myotube formation (summarized in Table I ). When10^g/ml of ConA was added to the medium,the cells were apt to dissociate from the dish. Typical shapes of the cells in the presence of WGA(2 fig/ml) are shown in Fig. 2E and F. At the concentration of 10 or 0.4^g/ml, WGA suppressed the cell proliferation or showed no effect, respectively (data not shown). MCK,a skeletal muscle specific enzyme, is induced to express by changing the medium to the differentiation medium. All of the lectins, ConA, DBA, SBA, PNA, lotus lectin, and UEA-I, that did not inhibit the myotube formation, also had no effect on the induction of MCK activity (Table I , group II). The three lectins, RCA-120, SSA, and MAMapparently inhibited both the myotube formation and the MCKactivity (Table I, group III) . RCA-120 and MAMsuppressed the cell growth. SSA inhibited the MCKactivity, but had no effect on the cell growth. The effect of the lectins on the myotubeformation in the group III may be complicated or indirect. Interestingly, WGA,AAL, and LCA, which apparently suppressed the myotube development, showed little effect on the MCKactivity (Table I , group I). The lectins in group I seemed to inhibit specifically the multinucleation step of the myotubeformation without affecting the biochemical differentiation. However, AALand
LCAmade the cells aggregate. Therefore, we next exam- The MCKactivity started to increase after 24 h incubation in the differentiation medium and rapidly increased thereafter (Fig. 3) . The increasing profile of the MCKactivity in the presence of WGAwas almost identical to that in the absence of WGA. It was confirmed that WGA, which apparently suppressed the myotube development, showed little effect on the MCK activity. WGA specifically recognizes and binds to N-acetylglucosamine (GlcNAc), oligo-saccharides containing GlcNAc (24, 25), and sialic acids (26). As shown in Fig.  3 , GlcNAc did not affect the MCKinduction. If the inhibitory effect of WGAwas due to the specific binding to the cell surface, GlcNAc and its trisaccharide, TAC, which are the specific ligands for WGAwith dissociation constants of 0.76 mMand 12 fiM, respectively (24), should restore the suppression of myotube development. In fact, three days after the mediumwas changed to Cosmedium, C2C12 cells showed normal myotubes when WGAwas added with 20 mMGlcNAc or 200 fiM TAC (Fig. 4) . WGA is also known to bind to sialic acids. Wetested whether or not Japanese horseshoe crab lectin (TTA), which is known to recognize N-acetylneuraminic acid (one of the sialic acids), also suppressed the myotube development. WGA(2 fig/ml ) clearly inhibited the myotube development of MTR4C, while TTA(10 /ig/ml) had no effect on that step (Fig.   5 ). Therefore, it was strongly suggested that WGA suppressed the myotube development by recognizing GlcNAc containing sugar.
WGAdid not actually inhibit the myoblast fusion. Membrane fusion is the initial step for the myotube formation. However, it was difficult to accurately quantify the step. To evaluate the extent of the fusion of C2C12 cells, the ratio of the numbers of mononucleated cells to the total DNAcontent (=amount of nuclei) was measured. Whenthe cells start to fuse, the parameter is expected to drop. The mononucleated cells were dissociated with trypsin and EDTAand counted in a hemocytometer. After the mediumwas changed to the differen- tiation medium, in the presence or absence of WGA, the numbers of the mononucleated cells and the amount of DNAper dish were measured. After 36 h incubation, the cell numbers reached twice that of time 0 and decreased thereafter (Fig. 6A) . The DNAcontent increased as well, but did not drop after 36 h incubation (Fig. 6B) . As a result, the ratio of cell numbers to DNA content dropped after 36 h incubation (Fig. 6C) . Multinucleation (=cell fusion) occurred actively at this period. This was supported by morphological observations. This, surprisingly, was also observed for the cells added to which WGAwas added (Fig. 6) . The result clearly indicates that the addition of WGAto the differentiation mediumdid not inhibit the cell fusion, the initial step of the myotube formation.
Wenext examined the expression of skeletal muscle myosin in the cells cultured in the presence of WGA. If the myoblasts in the presence of WGAwere really fused and formed multinucleated cells, visualization of the skeletal muscle myosin by immunostaining would make it celar. Immunostained C2C12 and MTR4Ccells with anti-myosin antiserum are shown in Fig. 7 . Both C2C12 and MTR4Ccells expressed myosin in the presence of 2 fjtg/ml of WGA( Fig. 7C and D) . The expressed skeletal muscle myosin was found in the myotubes that were very thin but their length was as long as those formed in the absence of WGA. Thus, it was confirmed that WGA did not inhibit the myoblast fusion. The cells stained with anti-myosin antibody and haematoxylin showed that the very thin myotubes found in the presence of WGAactually contained multiple nuclei (Fig. 7F) . Interestingly, the numbers of non-fused cells that did not express myosinin the presence or absence of WGA were similar ( Fig. 7E and F, and refer to Fig. 6A ). The shapes of the myotubes in the presence or absence of WGAwere similar to each other until 21 h incubation in Cosmedium (data not shown), and the inhibitory effect of WGAbecame clear only after the 48 h incubation ( Fig. 7E and F) .
DISCUSSION
In the present study, we tested the effect of 12 lectins on the myotube formation of C2C12cells. Amongthe lectins tested, WGA suppressed the myotube development, but apparently had no effect on the MCKinduetion. Although WGA seemed to suppress the myotube development, the index for the fusion (Fig. 6C ) and the immunostaining of the cells with anti-skeletal muscle myosin antiserum (Fig. 7) revealed that WGAdid not inhibit the initial step of the process. The inhibitory action of WGAwas on the development of the fused myotubes into large and extended ones. The myotubes formed in the presence of WGA contained less nuclei per length than those in the absence of WGA( Fig. 7E  and F) . Wepropose that the cell fusion process to form myotubes is composed of two distinct steps; one is to form long and thin myotubes and the other is to form fat and extended myotubes, which is schematically illustrated in Fig. 8 . At present, we do not have direct evidence that the cell fusion along the long axis to form the thin myotube precedes that of the fusion along the short axis, as shown in Fig. 8 . However, significant amounts of the long and thin myotubes were found in the immunostained MTR4Ccells after 48 h incubation even in the absence of WGA (Fig. 7B) . It seems likely that the myoblasts that are in contact with the end of the long axis fuse first to form long and thin myotubes, and that the myoblasts or the other thin myotubes then fuse to the primary myotubes to form the fat and ex- Fig. 9 . Effect of anti-VLA4 antibody on the myotube development in MTR4C.The cells were incubated without (A), or with 2 //g/ml of WGA (B), 25 /ig/ml (C), or 50 /ig/ml (D) of PS/2 in Cosmedium. The antibody was added after 6 h incubation in Cosmedium. The micrographs were taken after 48 h incubation. The bar indicates 100^m.
tended shape.
As to be molecule targeted by WGAto inhibit the secondary fusion of the myoblasts, GlcNAc (24) and sialic acids (26) are reported to be the specific ligands for WGA. Actually, GlcNAcand its trisaccharide suppressed the inhibition of WGA (Fig. 4) , and Japanese horseshoe crab lectin that specifically binds to N-acetylneuraminic acid (27), one of the sialic acids, showed no effect on the myotube formation. Therefore, it was suggested that WGAinhibited the myotube development through recognizing GlcNAc containing sugar. At present, four membrane glycoproteins, N-CAM (1, 2, 4) , N-cadherin (3), VLA-4 (integrin a4/31), and VCAM-1(5), are reported to be involved in the myogenesis. N-CAM utilizes muscle specific exons whenthe cells differentiate into myotubes (28) (29) (30) , and the introduction of the CDNA containing this muscle specific domain into the myoblasts promotes the myotube formation (3, 4). The specific antibody against the molecule produced from the introduced CDNApartially suppresses the myogenesis (3, 4). However, peanut lectin (PNA), which specifically binds to the 0-linked glycosylation site of the muscle specific domain (31), did not inhibit the myotube formation of C2C12 (Table I) . NCAMmight not be the target of WGA. On the other hand, 100 //g/ml of anti-VLA-4 (integrin a4/31) monoclonal antibody, PS/2, or anti-VCAM-1 monoclonal antibody, MK/1, inhibits the myoblast fusion of C2C12 very efficiently (5). In another study 100 fig/ml of the monoclonal antibody PS/2 (generously provided by
Dr. Miyake at Saga Medical School) (32) inhibited not only the myoblast fusion, but also the expression of myosin (data not shown). Less than 10 fig/ml of PS/2 showed no effect on the myotube formation, but 25 or 50 fig/ml of PS/2 partially inhibited the development of the myotube formation, similar to that of 2 fig/ml of WGA (Fig. 9) . The myosin expression was induced in the presence of 25 or 50ptg/ml of PS/2 (data not shown). In addition, the receptor for fibronectin, knownas a memberof integrin family, is reported to bind to WGA(33, 34) . It is reasonable to speculate that VLA-4is the best candidate of the target of WGA. A discrepancy exists however, since in C2C12, aA subunit of VLA-4is not expressed in myoblasts but in the cells that are induced to differentiate (5), while, in the present study, WGAhad to be present at very beginning of the induction of the differentiation for the inhibition. WhenWGA was added to C2C12 cells after 24h incubation in Cosmedium, the added WGAcould not suppress the myotube development anymore (data not shown). Further experiments are needed to determine which molecule is the target of WGA.
